Amino Acid Sequence Determinants of Extended Spectrum Cephalosporin Hydrolysis by the Class C P99 β-Lactamase*
暂无分享,去创建一个
Yang Yu | James M. Musser | Timothy Palzkill | Zhen Zhang | J. Musser | T. Palzkill | Yang Yu | Zhen Zhang
[1] Wanzhi Huang,et al. Cephalosporin Substrate Specificity Determinants of TEM-1 β-Lactamase* , 1997, Journal of Biological Chemistry.
[2] J Davies,et al. Inactivation of antibiotics and the dissemination of resistance genes. , 1994, Science.
[3] I. Taylor,et al. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. , 1998, Journal of molecular biology.
[4] T. Grundström,et al. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Petrosino,et al. β-Lactamases: protein evolution in real time , 1998 .
[6] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[7] J. Frère,et al. The roles of residues Tyr150, Glu272, and His314 in class C β‐lactamases , 1996 .
[8] O. Herzberg,et al. Crystal structure of the wide-spectrum binuclear zinc beta-lactamase from Bacteroides fragilis. , 1996, Structure.
[9] K. Bush,et al. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme , 1994, Antimicrobial Agents and Chemotherapy.
[10] T. Palzkill,et al. The Role of Residue 238 of TEM-1 β-Lactamase in the Hydrolysis of Extended-spectrum Antibiotics* , 1998, The Journal of Biological Chemistry.
[11] S. Ichiyama,et al. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam , 1993, Antimicrobial Agents and Chemotherapy.
[12] T. Yoshida,et al. Nucleotide sequence of the Serratia marcescens SR50 chromosomal ampC beta-lactamase gene. , 1990, FEMS microbiology letters.
[13] S. Mobashery,et al. Class C β-Lactamases Operate at the Diffusion Limit for Turnover of Their Preferred Cephalosporin Substrates , 1999, Antimicrobial Agents and Chemotherapy.
[14] A F Goddard,et al. Getting to the route of Helicobacter pylori treatment. , 1998, The Journal of antimicrobial chemotherapy.
[15] Stephen J. Benkovic,et al. Metallo-β-lactamase: structure and mechanism , 1999 .
[16] Peter S. Shenkin,et al. Amino Acid Sequence Determinants of β-Lactamase Structure and Activity , 1996 .
[17] J. Frère,et al. Role of residue Lys315 in the mechanism of action of the Enterobacter cloacae 908R beta-lactamase. , 1994, Biochemistry.
[18] A. Mentis,et al. Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae , 1994, Antimicrobial Agents and Chemotherapy.
[19] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[20] G S Weston,et al. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design. , 1998, Biochemistry.
[21] J. Frère,et al. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. , 2000, Biochemistry.
[22] T. Sawai,et al. A survey of a functional amino acid of class Cβ‐lactamase corresponding to Glu166 of class A β‐lactamases , 1993 .
[23] M. Gazouli,et al. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2) , 1996, Antimicrobial agents and chemotherapy.
[24] M. Francia,et al. Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica , 1992, Antimicrobial Agents and Chemotherapy.
[25] A. Huletsky,et al. Structure-Function Studies of Ser-289 in the Class C β-Lactamase from Enterobacter cloacae P99 , 1999, Antimicrobial Agents and Chemotherapy.
[26] R. Pratt,et al. Effect of the 3'-leaving group on turnover of cephem antibiotics by a class C beta-lactamase. , 1989, The Biochemical journal.
[27] F. Baquero,et al. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants , 1994, Antimicrobial Agents and Chemotherapy.
[28] G. Jacoby,et al. More extended-spectrum beta-lactamases , 1991, Antimicrobial Agents and Chemotherapy.
[29] B. Shoichet,et al. Crystal Structures of Substrate and Inhibitor Complexes with AmpC β-Lactamase: Possible Implications for Substrate-Assisted Catalysis , 2000 .
[30] J. Frère,et al. Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Busby,et al. Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase. , 1990, The Biochemical journal.
[32] J. Frère,et al. Catalytic mechanism of active-site serine beta-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad. , 1994, The Biochemical journal.
[33] J. Brosius,et al. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. , 1983, Gene.
[34] I. Stemplinger,et al. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes , 1996, Antimicrobial agents and chemotherapy.
[35] S. Mobashery,et al. Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. , 1992, Biochemistry.
[36] D. Botstein,et al. Probing β‐lactamase structure and function using random replacement mutagenesis , 1992 .
[37] J. Frère,et al. Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. , 1988, The Biochemical journal.
[38] A. Kuzin,et al. Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. , 1995, Biochemistry.
[39] J. Ghuysen,et al. Serine beta-lactamases and penicillin-binding proteins. , 1991, Annual review of microbiology.
[40] G. Papanicolaou,et al. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae , 1990, Antimicrobial Agents and Chemotherapy.
[41] T. Sawai,et al. Molecular Evolution of a Class C -Lactamase Extending Its Substrate Specificity (*) , 1995, The Journal of Biological Chemistry.
[42] L. Hall,et al. Sequence analysis of two chromosomally mediated inducible beta-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase. , 1995, The Journal of antimicrobial chemotherapy.
[43] R. Venezia,et al. Nucleotide Sequence of the ChromosomalampC Gene of Enterobacter aerogenes , 2000, Antimicrobial Agents and Chemotherapy.
[44] G. Bou,et al. Cloning, Nucleotide Sequencing, and Analysis of the Gene Encoding an AmpC β-Lactamase in Acinetobacter baumannii , 2000, Antimicrobial Agents and Chemotherapy.
[45] J. Frère,et al. The 3‐D structure of a zinc metallo‐beta‐lactamase from Bacillus cereus reveals a new type of protein fold. , 1995 .
[46] U. Ullmann,et al. A Novel Type of AmpC β-Lactamase, ACC-1, Produced by a Klebsiella pneumoniae Strain Causing Nosocomial Pneumonia , 1999, Antimicrobial Agents and Chemotherapy.
[47] J M Hughes,et al. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. , 1996, JAMA.
[48] P. Lagrange,et al. Characterization of FOX-3, an AmpC-Type Plasmid-Mediated β-Lactamase from an Italian Isolate ofKlebsiella oxytoca , 1998, Antimicrobial Agents and Chemotherapy.
[49] T. Sawai,et al. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion. , 1999, Biochemistry.
[50] A. Fersht. Enzyme structure and mechanism , 1977 .
[51] J. Frère,et al. The role of lysine-67 in a class C β-lactamase is mainly electrostatic , 1994 .
[52] J. Frère,et al. Molecular evolution of bacterial β-lactam resistance , 1996 .
[53] F. Winkler,et al. Refined crystal structure of β-lactamase from Citrobacter freundiiindicates a mechanism for β-lactam hydrolysis , 1990, Nature.
[54] B. Shoichet,et al. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. , 2001, Chemistry & biology.
[55] T. Sawai,et al. Effect of an amino acid insertion into the omega loop region of a class C beta-lactamase on its substrate specificity. , 1998, Biochemistry.
[56] J. Petrosino,et al. Contributions of Aspartate 49 and Phenylalanine 142 Residues of a Tight Binding Inhibitory Protein of β-Lactamases* , 1999, The Journal of Biological Chemistry.